# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-070884
Filing Date
2026-06-23
Accepted
2026-06-23 09:28:27
Documents
47
Period of Report
2026-06-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0295622-6k_purple.htm | 6-K | 9340
2 | PURPLE BIOTECH CORPORATE PRESENTATION JUNE 2026 | ea029562201ex99-1.htm | EX-99.1 | 67531
3 | GRAPHIC | ea029562201_ex99-1img1.jpg | GRAPHIC | 298668
4 | GRAPHIC | ea029562201_ex99-1img2.jpg | GRAPHIC | 652392
5 | GRAPHIC | ea029562201_ex99-1img3.jpg | GRAPHIC | 273340
6 | GRAPHIC | ea029562201_ex99-1img4.jpg | GRAPHIC | 248864
7 | GRAPHIC | ea029562201_ex99-1img5.jpg | GRAPHIC | 362177
8 | GRAPHIC | ea029562201_ex99-1img6.jpg | GRAPHIC | 327448
9 | GRAPHIC | ea029562201_ex99-1img7.jpg | GRAPHIC | 296873
10 | GRAPHIC | ea029562201_ex99-1img8.jpg | GRAPHIC | 244074
11 | GRAPHIC | ea029562201_ex99-1img9.jpg | GRAPHIC | 284701
12 | GRAPHIC | ea029562201_ex99-1img10.jpg | GRAPHIC | 216719
13 | GRAPHIC | ea029562201_ex99-1img11.jpg | GRAPHIC | 334363
14 | GRAPHIC | ea029562201_ex99-1img12.jpg | GRAPHIC | 267214
15 | GRAPHIC | ea029562201_ex99-1img13.jpg | GRAPHIC | 387230
16 | GRAPHIC | ea029562201_ex99-1img14.jpg | GRAPHIC | 369076
17 | GRAPHIC | ea029562201_ex99-1img15.jpg | GRAPHIC | 355637
18 | GRAPHIC | ea029562201_ex99-1img16.jpg | GRAPHIC | 219385
19 | GRAPHIC | ea029562201_ex99-1img17.jpg | GRAPHIC | 369848
20 | GRAPHIC | ea029562201_ex99-1img18.jpg | GRAPHIC | 359980
21 | GRAPHIC | ea029562201_ex99-1img19.jpg | GRAPHIC | 372810
22 | GRAPHIC | ea029562201_ex99-1img20.jpg | GRAPHIC | 236311
23 | GRAPHIC | ea029562201_ex99-1img21.jpg | GRAPHIC | 258093
24 | GRAPHIC | ea029562201_ex99-1img22.jpg | GRAPHIC | 262946
25 | GRAPHIC | ea029562201_ex99-1img23.jpg | GRAPHIC | 329532
26 | GRAPHIC | ea029562201_ex99-1img24.jpg | GRAPHIC | 227652
27 | GRAPHIC | ea029562201_ex99-1img25.jpg | GRAPHIC | 273541
28 | GRAPHIC | ea029562201_ex99-1img26.jpg | GRAPHIC | 221711
29 | GRAPHIC | ea029562201_ex99-1img27.jpg | GRAPHIC | 281369
30 | GRAPHIC | ea029562201_ex99-1img28.jpg | GRAPHIC | 176584
31 | GRAPHIC | ea029562201_ex99-1img29.jpg | GRAPHIC | 257264
32 | GRAPHIC | ea029562201_ex99-1img30.jpg | GRAPHIC | 398716
33 | GRAPHIC | ea029562201_ex99-1img31.jpg | GRAPHIC | 279981
34 | GRAPHIC | ea029562201_ex99-1img32.jpg | GRAPHIC | 299422
35 | GRAPHIC | ea029562201_ex99-1img33.jpg | GRAPHIC | 352630
36 | GRAPHIC | ea029562201_ex99-1img34.jpg | GRAPHIC | 406376
37 | GRAPHIC | ea029562201_ex99-1img35.jpg | GRAPHIC | 332104
38 | GRAPHIC | ea029562201_ex99-1img36.jpg | GRAPHIC | 423664
39 | GRAPHIC | ea029562201_ex99-1img37.jpg | GRAPHIC | 385433
40 | GRAPHIC | ea029562201_ex99-1img38.jpg | GRAPHIC | 274415
41 | GRAPHIC | ea029562201_ex99-1img39.jpg | GRAPHIC | 406011
42 | GRAPHIC | ea029562201_ex99-1img40.jpg | GRAPHIC | 269880
43 | GRAPHIC | ea029562201_ex99-1img41.jpg | GRAPHIC | 336378
44 | GRAPHIC | ea029562201_ex99-1img42.jpg | GRAPHIC | 417429
45 | GRAPHIC | ea029562201_ex99-1img43.jpg | GRAPHIC | 335435
46 | GRAPHIC | ea029562201_ex99-1img44.jpg | GRAPHIC | 410019
47 | GRAPHIC | ea029562201_ex99-1img45.jpg | GRAPHIC | 181287
| Complete submission text file | 0001213900-26-070884.txt |  | 19518638

Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261109202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)